California 2021-2022 Regular Session

California Senate Bill SB41

Introduced
12/7/20  
Introduced
12/7/20  
Refer
1/28/21  
Refer
1/28/21  
Report Pass
3/10/21  
Report Pass
3/10/21  
Refer
3/11/21  
Refer
3/11/21  
Report Pass
5/20/21  
Report Pass
5/20/21  
Engrossed
5/28/21  
Engrossed
5/28/21  
Refer
6/3/21  
Refer
6/14/21  
Refer
6/14/21  
Refer
6/17/21  
Refer
6/17/21  
Report Pass
7/1/21  
Report Pass
7/1/21  
Refer
7/1/21  
Refer
7/1/21  
Report Pass
7/13/21  
Report Pass
7/13/21  
Refer
7/13/21  
Refer
7/13/21  
Report Pass
8/26/21  
Report Pass
8/26/21  
Enrolled
9/9/21  
Enrolled
9/9/21  
Chaptered
10/6/21  
Chaptered
10/6/21  
Passed
10/6/21  

Caption

Privacy: genetic testing companies.

Impact

The passage of SB 41 directly impacts state laws concerning genetic information, significantly tightening regulations. It aims to prevent misuse of genetic data while ensuring consumers have control over personal information. Companies that fail to comply may face civil penalties, highlighting the state’s commitment to consumer rights in the digital age. Moreover, the law establishes that it does not diminish existing federal and state obligations related to privacy and security, thus reinforcing a multi-layered protective framework for consumer data.

Summary

Senate Bill No. 41, known as the Genetic Information Privacy Act, aims to enhance the privacy protections surrounding genetic data collected by direct-to-consumer genetic testing companies. The bill requires these companies to provide explicit information about their policies on the collection, use, and disclosure of genetic data, as well as to secure express consent from consumers before proceeding. Additionally, it stipulates that consumers must be given a mechanism to revoke consent easily, with the requirement that biological samples be destroyed within 30 days of such a revocation. This legislation builds upon existing protections provided under the California Consumer Privacy Act of 2018, reinforcing the rights of consumers over their own genetic data.

Sentiment

Overall, the sentiment surrounding the bill is supportive, particularly among consumer advocacy groups who view it as a necessary advancement in the protection of personal genetic information. However, there may be concerns from businesses affected by the regulations, potentially seeing the requirements as cumbersome or an impediment to operations. The measure reflects a growing recognition of the sensitivity of genetic data, which has implications for personal privacy and potential discrimination.

Contention

Some points of contention include the balance between consumer protection and business operations. Critics may argue that the stringent requirements could stifle innovation in the genetic testing market, making it more challenging for companies to operate. Additionally, discussions around whether existing laws sufficiently protect consumer rights could arise, particularly regarding the enforcement mechanisms established by the bill, which relies on state prosecution rather than allowing private lawsuits.

Companion Bills

No companion bills found.

Similar Bills

CA SB980

Privacy: genetic testing companies.

RI S0767

Establishes the Genetic Information Privacy Act, which would require a direct-to-consumer genetic testing company, as defined, to provide a consumer with certain information regarding the company’s policies and procedures regarding use of genetic data.

CA AB694

Privacy and Consumer Protection: omnibus bill.

CA SB1121

California Consumer Privacy Act of 2018.

CA AB873

California Consumer Privacy Act of 2018.

CA SB1223

Consumer privacy: sensitive personal information: neural data.

LA HB947

Provides relative to the protection of data

CA AB3286

California Consumer Privacy Act of 2018: monetary thresholds: grants.